Please assess the completion status of the following clinical trial:

Trial Title: Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with right-heart catheterization~* Clinical indication for thoracic CT~Exclusion Criteria:~* Pregnancy~* Decreased kidney function~* Intolerance to contrast material~* Other standard CT contraindications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Pulmonary arterial hypertension (PAH) (Type: None): The patients with PAH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- PH due to left-heart disease (PH-LHD) (Type: None): The patients with PH-LHD received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- Chronic thromboembolic pulmonary hypertension (CTEPH) (Type: None): The patients with CTEPH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- PH due to emphysema (PH-LD-Emphys) (Type: None): The patients with PH-LD-Emphys received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- PH due to lung fibrosis (PH-LD-Fibr) (Type: None): The patients with PH-LD-Fibr received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- PH due to combined emphysema and fibrosis (PH-LD-CPFE) (Type: None): The patients with PH-LD-CPFE received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.
- No PH (Type: None): The patients without PH received an invasive right-heart catheterization and a thoracic CT scan as part of their routine work up.

Based on this trial design, predict the completion outcome and termination type (if applicable).